U.S. preeclampsia laboratory testing market will rise at a healthy CAGR of 5.1% during the forecast period of 2021-2026, reaching a market volume of ~4,629,000 by 2026. As countries undergo an escalated rate of health-related risks, preeclampsia is reported as the third leading cause of maternal mortality in the U.S alone.

The scope of reproductive care now widely encompasses preeclampsia screening. This is projected to take the demand for preeclampsia laboratory testing to new heights in the coming decade.  Undiagnosed and untreated preeclampsia has been a major cause for fetal and maternal mortality. This can be prevented through efficient preeclampsia diagnosis. Additionally, the number of COVID-19-positive pregnant women is on the rise which is increasing their chances of developing this fatal condition.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables Figures, Chart) : https://www.fairfieldmarketresearch.com/report/us-preeclampsia-laboratory-testing-market/request-sample

Severe Preeclampsia Emerges as a Notable Market Segment Becoming the Leading Cause for the Popularity of Preeclampsia Laboratory Testing

The preeclampsia laboratory testing market primarily benefits from two factors - a high prevalence of preeclampsia in developing countries, coupled with several product launches to cater to this surging caseload. Cases of severe preeclampsia have been mushrooming in recent times, generating palpable alarm across the healthcare sector. Blood tests hold a sizeable lead in the test type category of the preeclampsia laboratory testing market and this propensity is not projected to undergo major deviances in the times to follow. Patients opt for blood tests over other options because of their higher accuracy rates.

Furthermore, several novel biomarkers have been launched in the preeclampsia laboratory testing market recently. Although Hospitals Clinics segment dominates the end user segment throughout the forecast period with ~40% market share in 2026, diagnostic centres are the fastest growing category among end users.  

U.S. Leads in Preeclampsia Laboratory Testing on Account of the Country’s Proactive Healthcare Workforce and Robust Infrastructure

The healthcare industry in the U.S. has played a preeminent role in improving preeclampsia laboratory testing across the region. The presence of numerous patient advocacy groups as well as government initiatives to develop better diagnostics regimen in the U.S. are strong contributors to the regional market’s dominance. The US Preventive Services Task Force has been making dedicated efforts to ensure proper management of screening tests. This is a critical success factor for the growth of the regional market. The regional market is also expected to witness rife growth opportunities, attracting interest of healthcare and pharmaceutical companies active in preeclampsia laboratory testing segment.

Companies Dominating the Global Market for Preeclampsia Laboratory Testing Reported to be Headquartered in the U.S

Two of the three companies that take up sixty percent of the global preeclampsia laboratory market have their headquarters in the U.S. These are Thermo Fischer Scientific and PerkinElmer along with their Swiss competitor F. Hoffmann-La Roche.

Moreover, several companies involved in the concerned testing are offering effective diagnostics through collaborations with esteemed research organizations in the region. Along with this, SERA Prognostics, Siemens Healthineers AG, Progenity Inc., Metabolomic Diagnostics Ltd., DiabetOmics Inc., and Bayer AG are some of the big names operating in the preeclampsia laboratory market.

𝐅𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐈𝐧𝐬𝐢𝐠𝐡𝐭 𝐑𝐞𝐚𝐝: https://www.fairfieldmarketresearch.com/report/us-preeclampsia-laboratory-testing-market

About Us 

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published updated to ensure the ever-changing needs of customers are met with absolute promptness. 

Contact 

Fairfield Market Research  

London, UK 

UK +44 (0)20 30025888     

USA (Toll-free) +1 (844) 3829746  

Web: https://www.fairfieldmarketresearch.com/  

Email: sales@fairfieldmarketresearch.com 

Follow Us: LinkedIn